How does a patient benefit from the use of a new medicine? Does he live longer, does quality of life improve relatively? And does the new drug contribute to the affordability of our care system? Martin Eijgenhuijsen reflects on an impact project.
A European initiative Sustainable finance is gaining momentum. And gladly so. Last week the European Commission presented its action plan Financing Sustainable Growth. Eloy Lindeijer reflects.
PGGM has received the results of two impact measurement projects that we’ve set up with two pharmaceutical companies. These data can help us to become a better impact investor, writes Martin Eijgenhuijsen.
PGGM has mapped the investment portfolio by its effects on people and planet. A learning experience, according to Piet Klop and Cedric Scholl.
There is value in exploring the concept of human rights: it will make us smarter investors, says Jelena Stamenkova-van Rumpt.
Investments in solutions to water scarcity can be made worldwide, far away, and close to home, says Piet Klop.
The real estate portfolios managed by PGGM have been measured against the annual GRESB sustainability yardstick again. The result is a more and more sustainable real estate portfolio, writes Mathieu Elshout.
PGGM and other Dutch investors and companies propose indicators to measure the impact of their assets to the Sustainable Development Goals.
